Medically reviewed by Renita White, MD Cancer that develops in the ovaries (the egg-producing reproductive organs) is ...

AROUND 7,500 women are diagnosed with ovarian cancer each year in the UK and 4,100 pass away from it. But symptoms of the ...

Ovarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...

numbered 1 to 4. Stage 3 ovarian cancer has spread outside the pelvis into the abdominal cavity or to lymph nodes. Treatment includes surgery and chemotherapy. Stage 3A1 means the cancer has spread to ...

NORTH CHICAGO, IL, USA I March 15, 2025 I AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the ...

The goal is to take out all visible cancer and tumors larger than 1 centimeter ... About 20% to 30% of people with stage III ovarian cancer, and 40% to 60% of people who have stage IV, receive ...

Remission rates for ovarian cancer patients remained stable before ... followed by stage I (27.8%), stage IV (21.5%), and stage II (11.1%). However, no statistically significant differences ...

The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα expression of 25% or greater -SOUTH SAN FRANCISCO, Calif., March 15, ...

In 2013, Mary Lou Polo was given just a week to live. She had stage IV ovarian cancer, and her chances of survival were grim. This September, more than 10 years later, Polo recently celebrated her ...

AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE� (mirvetuximab soravtansine-gynx) in women with folate ...